Insulin port device co gets $15m boost:
This article was originally published in Clinica
Executive Summary
Austin, Texas-based Patton Medical Devices is ramping up US sales of its I-Port injection port, after receiving $15m from institutional investors. This brings the total investment in the company to $27m. The company's device incorporates a tube that is inserted into the skin, providing diabetics with a readily available channel for injecting their insulin and reducing the need for repeated piercing of the skin. The port can accommodate 75 injection and be worn for up to 72 hours.